The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific And Abbott Laboratories

 | Mar 10, 2020 09:15PM ET

For Immediate Release

Chicago, IL – March 11, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Medtronic (NYSE:MDT) , Boston Scientific Corp. (NYSE:BSX) and Abbott Laboratories (NYSE:ABT) .

Here are highlights from Tuesday’s Analyst Blog:

Coronavirus Ails S&P 500, MedTech Bears the Brunt

The novel coronavirus catastrophe continues to take a massive toll on the stock market. Yesterday was the worst day for the market since the 2008 financial crisis, so much so that it was termed as ‘Black Monday.’ Among the major indices, Dow Jones tanked more than 2000 points while the NASDAQ Composite Index shed 625 points. The S&P 500 Index closed 226 points lower, marking a 7.6% decline in a single day. Taking into consideration the huge daily trading volume of stocks on this coveted index, this massive fall is really appalling.

While an unexpected oil price cut in Saudi Arabia over the weekend contributed to this decline, the 2019-nCoV or COVID 19 continues to send jitters across share markets. Per the last reported figure, the death toll reached 4027. Over the last weekend, daily death growth factor exceeded 1, a clear sign that the number of deaths will increase.

Investors are quite apprehensive about the current market scenario, making the overall situation more critical. Following last week’s emergency rate cut by Fed, the World Bank and IMF’s declaration of a respective $12 billion and $50 billion of support to control the economic fallout of all COVID-19-affected countries, market watchers are linking the latest rate cut as a clear indicator of another economic recession impending.

Going by a Original post

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes